SHSybil HosekPhDSlidesetHIVHIV Prevention Review Meeting 2022HIV Prevention in Adolescents - Sybil Hosek, PhDView Slideset
KJJKai J. JonasPhDSlidesetHIVHIV Prevention Review Meeting 2022HIV Prevention in Transgender People - Kai J. Jonas, PhDView Slideset
RERichard ElionMDSlidesetHIVHIV Prevention Review Meeting 2022Existing Drugs and Strategies for PrEP - Richard Elion, MDView Slideset
MLMaureen LubaSlidesetHIVHIV Prevention Review Meeting 2022CON - Healthcare Provider and Community Perspectives - François Venter, MD, FCP, PhDView Slideset
SlidesetHIVHIV Prevention Review Meeting 2022Existing Drugs and Strategies for PEP - Elizabeth Anne Bukusi, MBChB, M.Med& Victor Ocholla Omollo MBChB, MPHView Slideset
JFJohn FlahertyPharmDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Bulevirtide - Data from Real World Usage after Approval in Europe - John FlahertyView Slideset
GWGrace WangMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Development of Assembly Next Generation Core Inhibitors - Grace WangView Slideset
ETEmily ThiPhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Evidence of T Cell Restoration after siRNA Therapy - Emily ThiView Slideset
MBMichael BiermerMDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Cam-N Jnj-6379. Lessons Learned From Reef-1 and -2 Studies - Michael BiermerView Slideset
BTBarbara TestoniPhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022How HBV RNA and HBcrAg Relate to cccDNA Transcriptional Activity - Barbara TestoniView Slideset
GLGeorg LauerPhD, MDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022HBV-Specific T Cell Profile Associated with Functional Cure - Georg LauerView Slideset
PLPietro LamperticoMD, PhDSlidesetViral Hepatitis and Liver DiseaseInternational Workshop on HBV Cure 2022Why We Should Be Careful Using NA Withdrawal as a Therapeutic Option - Pietro LamperticoView Slideset
